No abstract

Historically, states have used Certificate of Need (CON) programs to review proposals for new construction and expanded services in an effort to control costs and to improve the quality of and promote access to health care services. Congressional funding for CON ended in 1987. However, today, 26 states use CON to regulate cardiac surgery. There has been little evidence of the impact of CON on the quality of services. Pennsylvania is in a unique position to study the impact of CON on the quality and outcomes of care because the state terminated CON in 1996 and has publicly reported quality and outcomes data on coronary bypass graft (CABG) surgeries since 1992. Using a statewide inpatient data-reporting system, the volumes and outcomes of CABG surgeries at all Pennsylvania hospitals were examined in the 3 years prior to and the 3 years after the termination of CON. In the 3 years following the elimination of CON, the number of open-heart surgery programs increased 25%, yet there was no significant increase in the number of CABG surgeries performed. Quality, as measured by mortality rate, was not impacted by the real-location of the relatively stable CABG volume in the short term; this may be due, in part, to itinerant surgeons and statewide public performance monitoring. The long-term implications of deregulation are unclear and deserve future study.

Many of the quality measures for patients with heart failure (HF) or acute myocardial infarction (AMI) require the completion of comprehensive discharge instructions, including instructions about medications to be taken after discharge. To improve compliance in a tertiary care teaching hospital with these evidence-based quality measures, a clinical-decision-support system (CDSS) that uses an electronic checklist was developed. The CDSS prompts clinicians at every training level to consistently create comprehensive discharge instructions addressing quality measures. The authors compared compliance during the 15-month preintervention and postintervention periods. Compliance with discharge measures for AMI (i.e., aspirin, beta-blocker, angiotensin-converting enzyme inhibitor [ACEI], or angiotensin receptor blocker [ARB] use) and for HF (i.e., discharge instructions, left ventricular systolic function [LVSF] evaluation, and ACEI/ARB use) was assessed. The delivery of discharge instructions showed significant improvement from the preintervention period to the postintervention period (37.2% to 93.0%; P < .001). Compliance with prescription of ACEI or ARB also improved significantly for HF (80.7% to 96.4%; P < .001) and AMI (88.1% to 100%; P = .014) patients. Compliance with the remaining measures was higher before intervention, and, thus, the modest improvement in the postintervention period was not statistically significant (AMI patients: aspirin, 97.5% to 98.8%; P = .43; and beta-blocker, 97.9% to 98.7%; P = .78; HF patients: LVSF, 99.3% to 99.1%; P = .78). Implementation of a CDSS with computerized electronic prompts improved compliance with selected cardiac-care quality measures. The design of quality-improvement decision-support tools should incorporate educational missions in their message and design.